Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Dermal Fillers Market: By Product Type, By Ingredient Type, Poly-L-Lactic Acid, Calcium Hydroxylapatite, Polymethylmethacrylate ), Polycaprolactone ), By End User and Region Forecast 2019-2030
Dermal Fillers Market size is expected to grow from US$ 3,416.0 million in 2023 to US$ 7,255.3 million by 2030 at a CAGR of 10% during 2024-2030. Dermal fillers are injectable treatments that can help to diminish the appearance of wrinkles while restoring volume and fullness in the face and hands or to reshape features to meet aesthetic goals, such as achieving a fuller lip or correcting the appearance of a recessed chin.
The market is primarily driven by the growing demand for minimally invasive aesthetic procedures, the increasing geriatric population, increasing awareness about cosmetic treatments, rise in beauty consciousness, and technological advancements in filler products. For instance, according to WHO, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2020 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. However, potential side effects, stringent regulatory approvals, and high costs associated with dermal fillers may pose challenges to market growth.
Furthermore, current breakthroughs such as HA filler for subtle lip enhancement that improves lip definition without increasing lip size will encourage a greater desire for dermal filler procedures. In recent years, both industrialized and developing countries have seen a considerable increase in facilities such as clinics, medical spas, and rejuvenation centers. As a result, the business will increase due to the fast adoption of various non-invasive therapies given by these facilities, which have advantages such as cost-effectiveness and shorter treatment times. A growing number of competent specialists, such as dermatologists and plastic surgeons, will also contribute to the industry's growth. Several players in the dermal fillers market are actively updating their research and development activities to come out with unique products and new launches. This factor will result in more revenues, eventually boosting the dermal fillers market's growth rate.
Study Period
2024-2030Base Year
2023CAGR
10%Largest Market
EuropeFastest Growing Market
North-America
The primary catalyst for the dermal fillers market's growth is the increasing desire for youthful appearance and non-invasive cosmetic procedures. The rise in disposable income, particularly in emerging economies, has made these treatments more accessible to a broader population. Technological advancements in filler materials and injection techniques have also contributed to market expansion, offering more natural-looking and longer-lasting results. The market is further propelled by the growing acceptance of aesthetic procedures among men and younger age groups.
Additionally, the increase in the geriatric population serves as the major catalyst of the dermal fillers market. As life expectancy increases and healthcare improves, more people are reaching old age, leading to what is known as the "silver surge." Dermal fillers are increasingly popular due to their ability to effectively address various signs of ageing, such as wrinkles and sagging skin, without the need for invasive surgery. According to the Population Reference Bureau, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase), and the 65-and-older age group’s share of the total population is projected to rise from 17% to 23%. On 1 January 2023, the EU population was estimated at 448.8 million people and more than one-fifth (21.3 %) of it was aged 65 years and over.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 3,416.0 million |
Market Size in 2030 |
US$ 7,255.3 million |
Market CAGR |
10% |
By Product Type |
|
By Ingredient |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global dermal fillers market size was valued at US$ 3,416.0 million in 2023 and is projected to grow at a CAGR of 10% from 2024 to 2030.
The USA is the biggest market in the dermal fillers space with a market size close to US$ 1.5 Billion.
Asia Pacific region is the fastest growing region in the dermal fillers market. In Asia Pacific, South Korea, China, and Japan are the top countries in terms of facial dermal fillers procedures.
Allergan, Merz, and Galderma are the key market players in the dermal fillers market with a cummulated market share close to 75% in 2023
1.Executive Summary |
2.Global Dermal Fillers Market Introduction |
2.1.Global Dermal Fillers Market - Taxonomy |
2.2.Global Dermal Fillers Market - Definitions |
2.2.1.Ingredient Type |
2.2.2.Product Type |
2.2.3.End User |
2.2.4.Region |
3.Global Dermal Fillers Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Dermal Fillers Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Dermal Fillers Market By Ingredient Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Hyaluronic Acid (HLA) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Poly-L-Lactic Acid (PLA) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Calcium Hydroxylapatite (CaH) |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Polymethylmethacrylate (PMMA) |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Dermal Fillers Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Absorbable Dermal Fillers |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Non-absorbable Dermal Fillers |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Dermal Fillers Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Aesthetic Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Cosmetic Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Dermal Fillers Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Dermal Fillers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Ingredient Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Hyaluronic Acid (HLA) |
9.1.2.Poly-L-Lactic Acid (PLA) |
9.1.3.Calcium Hydroxylapatite (CaH) |
9.1.4.Polymethylmethacrylate (PMMA) |
9.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Absorbable Dermal Fillers |
9.2.2.Non-absorbable Dermal Fillers |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Aesthetic Hospitals |
9.3.2.Cosmetic Clinics |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Dermal Fillers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Ingredient Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Hyaluronic Acid (HLA) |
10.1.2.Poly-L-Lactic Acid (PLA) |
10.1.3.Calcium Hydroxylapatite (CaH) |
10.1.4.Polymethylmethacrylate (PMMA) |
10.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Absorbable Dermal Fillers |
10.2.2.Non-absorbable Dermal Fillers |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Aesthetic Hospitals |
10.3.2.Cosmetic Clinics |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Dermal Fillers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Ingredient Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Hyaluronic Acid (HLA) |
11.1.2.Poly-L-Lactic Acid (PLA) |
11.1.3.Calcium Hydroxylapatite (CaH) |
11.1.4.Polymethylmethacrylate (PMMA) |
11.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Absorbable Dermal Fillers |
11.2.2.Non-absorbable Dermal Fillers |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Aesthetic Hospitals |
11.3.2.Cosmetic Clinics |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Dermal Fillers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Ingredient Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Hyaluronic Acid (HLA) |
12.1.2.Poly-L-Lactic Acid (PLA) |
12.1.3.Calcium Hydroxylapatite (CaH) |
12.1.4.Polymethylmethacrylate (PMMA) |
12.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Absorbable Dermal Fillers |
12.2.2.Non-absorbable Dermal Fillers |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Aesthetic Hospitals |
12.3.2.Cosmetic Clinics |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Dermal Fillers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Ingredient Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Hyaluronic Acid (HLA) |
13.1.2.Poly-L-Lactic Acid (PLA) |
13.1.3.Calcium Hydroxylapatite (CaH) |
13.1.4.Polymethylmethacrylate (PMMA) |
13.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Absorbable Dermal Fillers |
13.2.2.Non-absorbable Dermal Fillers |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Aesthetic Hospitals |
13.3.2.Cosmetic Clinics |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Galderma Pharma S.A |
14.2.2.Sinclair Pharma plc |
14.2.3.Zimmer Biomet Holdings |
14.2.4.Allergan plc. |
14.2.5.Anika Therapeutics Inc. |
14.2.6.Merz Pharma GmbH & Co. KGaA |
14.2.7.Suneva Medical Inc. |
14.2.8.Teoxane Laboratories Inc. |
14.2.9.Prollenium Medical Technologies Inc. |
14.2.10.Laboratoires Vivacy SAS |
14.2.11.Fidia Pharma USA Inc. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players